BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26434409)

  • 1. Silibinin suppresses astroglial activation in a mouse model of acute Parkinson's disease by modulating the ERK and JNK signaling pathways.
    Lee Y; Chun HJ; Lee KM; Jung YS; Lee J
    Brain Res; 2015 Nov; 1627():233-42. PubMed ID: 26434409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.
    Lee Y; Park HR; Chun HJ; Lee J
    J Neurosci Res; 2015 May; 93(5):755-65. PubMed ID: 25677261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective and anti-inflammatory effects of morin in a murine model of Parkinson's disease.
    Lee KM; Lee Y; Chun HJ; Kim AH; Kim JY; Lee JY; Ishigami A; Lee J
    J Neurosci Res; 2016 Oct; 94(10):865-78. PubMed ID: 27265894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baicalein attenuates astroglial activation in the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson's disease model by downregulating the activations of nuclear factor-κB, ERK, and JNK.
    Lee E; Park HR; Ji ST; Lee Y; Lee J
    J Neurosci Res; 2014 Jan; 92(1):130-9. PubMed ID: 24166733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
    Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
    Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
    Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG
    J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal model.
    Fujita A; Yamaguchi H; Yamasaki R; Cui Y; Matsuoka Y; Yamada KI; Kira JI
    J Neuroinflammation; 2018 Aug; 15(1):227. PubMed ID: 30103794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
    Kato H; Kurosaki R; Oki C; Araki T
    Brain Res; 2004 Dec; 1030(1):66-73. PubMed ID: 15567338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.
    Karunakaran S; Diwakar L; Saeed U; Agarwal V; Ramakrishnan S; Iyengar S; Ravindranath V
    FASEB J; 2007 Jul; 21(9):2226-36. PubMed ID: 17369508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice.
    Ren Z; Yang N; Ji C; Zheng J; Wang T; Liu Y; Zuo P
    Neuropharmacology; 2015 Jun; 93():209-18. PubMed ID: 25680233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's disease.
    Martin HL; Santoro M; Mustafa S; Riedel G; Forrester JV; Teismann P
    Glia; 2016 Mar; 64(3):386-95. PubMed ID: 26511587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iptakalim protects against MPP+-induced degeneration of dopaminergic neurons in association with astrocyte activation.
    Yang YJ; Zhang S; Ding JH; Zhou F; Hu G
    Int J Neuropsychopharmacol; 2009 Apr; 12(3):317-27. PubMed ID: 18700057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JNK-mediated microglial DICER degradation potentiates inflammatory responses to induce dopaminergic neuron loss.
    Wang Q; He Q; Chen Y; Shao W; Yuan C; Wang Y
    J Neuroinflammation; 2018 Jun; 15(1):184. PubMed ID: 29907159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
    Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
    Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of bee venom is mediated by reduced astrocyte activation in a subchronic MPTP-induced model of Parkinson's disease.
    Kim ME; Lee JY; Lee KM; Park HR; Lee E; Lee Y; Lee JS; Lee J
    Arch Pharm Res; 2016 Aug; 39(8):1160-70. PubMed ID: 27469335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model.
    Yadav SK; Prakash J; Chouhan S; Westfall S; Verma M; Singh TD; Singh SP
    Neurochem Int; 2014 Jan; 65():1-13. PubMed ID: 24333323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model.
    Yang W; Chen YH; Liu H; Qu HD
    Int J Mol Med; 2015 Nov; 36(5):1369-76. PubMed ID: 26648012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.